v3.5.0.2

Balance Sheet (Current Period Unaudited) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Current Assets:
Cash and cash equivalents	$ 324,386	$ 59,837
Prepaid expense		7,400
Other current asset	148,571
Total Current Assets	472,957	67,237
Other Assets:
Patent Rights and Trademark	30,400	10,400
Total Assets	503,357	77,637
Current Liabilities:
Accounts payable	5,000	15,000
Accrued liabilities	5,153
Officer's compensation payable	30,000
Payable to related party	12,359	102,172
Deposits		60,445
Total Current Liabilities	52,512	177,617
Total Liabilities	52,512	177,617
Commitments and Contingencies (Note 5)
Stockholders' Equity (Deficit):
Preferred stock, $0.0001 par value, 20,000,000 shares authorized; none issued and outstanding at June 30, 2016 and December 31, 2015, respectively
Common stock, $0.0001 par value, 500,000,000 shares authorized; 247,207,994 shares and 20,500,000 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively	24,721	2,050
Discount on common stock	(2,050)	(2,050)
Additional paid in capital	646,690	1,751
Deficit accumulated during development stage	(218,516)	(101,731)
Total Stockholders' Equity (Deficit)	450,845	(99,980)
Total Liabilities and Stockholders' Equity	$ 503,357	$ 77,637

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Amchi Gendynamy Science Corp 10-Q